Galapagos NV ADR (GLPG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GLPG | AZN | AMGN | GILD | VRTX |
| Company | Galapagos NV ADR | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 31.43 | 91.18 | 321.82 | 121.07 | 442.55 |
| High | 31.81 | 91.44 | 323.00 | 122.25 | 448.28 |
| Low | 31.41 | 89.78 | 313.17 | 119.02 | 436.49 |
| Latest | 31.63 | 89.82 | 313.85 | 119.36 | 437.01 |
| Change | +0.14 | -1.46 | -7.38 | -1.83 | -5.03 |
| % Change | +0.44% | -1.60% | -2.30% | -1.51% | -1.14% |
| Volume | 66,300 | 4,728,100 | 2,925,100 | 7,256,000 | 989,600 |
| 20-Day Average Volume | 115,270 | 5,520,425 | 2,946,440 | 7,122,410 | 1,395,790 |
| Previous Close | 31.49 | 91.28 | 321.23 | 121.19 | 442.04 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 31.29 | 90.29 | 337.05 | 124.53 | 435.40 |
| 20-Day Raw Stochastic | 50.17% | 38.17% | 2.03% | 7.68% | 42.56% |
| 20-Day Relative Strength | 49.56 | 56.78 | 45.39 | 44.97 | 53.71 |
| Weighted Alpha | +18.11 | +37.80 | +15.52 | +26.22 | -3.04 |
| Today's Opinion | 8% Buy | 88% Buy | 72% Buy | 56% Buy | 24% Buy |
| Previous Opinion | 8% Buy | 100% Buy | 80% Buy | 80% Buy | 24% Buy |
| Last Month's Opinion | 24% Buy | 100% Buy | 56% Buy | 88% Buy | 56% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.89% since 12/02/25 | -0.39% since 12/02/25 | -7.24% since 12/02/25 | -3.67% since 12/02/25 | +0.89% since 12/02/25 |
| Low | 31.19 on 12/03/25 | 89.67 on 12/08/25 | 313.17 on 12/09/25 | 119.02 on 12/09/25 | 436.49 on 12/09/25 |
| High | 31.98 on 12/04/25 | 91.44 on 12/09/25 | 346.38 on 12/03/25 | 125.60 on 12/03/25 | 463.85 on 12/03/25 |
| 1-Month | |||||
| %Chg | +0.32% since 11/07/25 | +6.20% since 11/07/25 | -1.98% since 11/07/25 | +0.44% since 11/07/25 | +6.73% since 11/07/25 |
| Low | 30.13 on 11/20/25 | 85.85 on 11/10/25 | 313.17 on 12/09/25 | 117.13 on 11/10/25 | 410.50 on 11/10/25 |
| High | 33.12 on 11/12/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 3-Month | |||||
| %Chg | -3.18% since 09/09/25 | +10.59% since 09/09/25 | +12.10% since 09/09/25 | +3.11% since 09/09/25 | +10.22% since 09/09/25 |
| Low | 29.81 on 11/05/25 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 37.78 on 10/03/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 6-Month | |||||
| %Chg | +12.60% since 06/09/25 | +23.02% since 06/09/25 | +8.23% since 06/09/25 | +5.63% since 06/09/25 | -2.05% since 06/09/25 |
| Low | 26.62 on 06/23/25 | 68.61 on 07/21/25 | 267.83 on 06/23/25 | 104.46 on 06/25/25 | 362.50 on 08/11/25 |
| High | 37.78 on 10/03/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,075,191 | 283,098,176 | 172,976,256 | 150,358,016 | 112,153,952 |
| Shares Outstanding, K | 65,900 | 3,101,426 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 298,280,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | 80,160,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 78,990,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -161,610,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 0.18 | 0.31 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.47 on 04/23/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 11/05/25 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 09/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 11/21/25 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.73 | 15.08 | 14.80 | 29.75 |